Virtual Library

Start Your Search

Ashley Levitan



Author of

  • +

    P3.11 - Screening and Early Detection (Not CME Accredited Session) (ID 977)

    • Event: WCLC 2018
    • Type: Poster Viewing in the Exhibit Hall
    • Track:
    • Presentations: 1
    • Moderators:
    • Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
    • +

      P3.11-07 - The Quality of Screening: Comparing the Rush Lung Cancer Screening Program to the NLST and the VA Lung Cancer Screening Demonstration Project (ID 13537)

      12:00 - 13:30  |  Author(s): Ashley Levitan

      • Abstract
      • Slides

      Background

      The National Lung Screening Trial (NLST) was conducted for the purpose of determining the efficacy of using a low dose computed tomography (LDCT) scan to screen for lung cancer screening versus chest x-ray. Findings demonstrated a reduction in mortality by 20.0%.

      In 2013, informed by the findings from the NLST, the United States Preventative Services Task Force (UPSTF) gave lung cancer screening a grade B recommendation. This recommendation eventually led to both private insurance coverage and in 2015, Centers for Medicare and Medicaid Services (CMS) coverage of low dose computed tomography (LDCT) scans to screen for lung cancer.

      In 2017, the US Department of Veterans Affairs (VA) published the experience of implementing a lung cancer screening program (LCSDP). This publication attracted the attention of the medical community and media, generating concern over the value of LDCT scans indicated to screen for lung cancer.

      The Rush University Medical Center Lung Cancer Screening Program (RLCSP) is in its third year of implementation and adheres to best practices for the evolving discipline of lung cancer screening.

      a9ded1e5ce5d75814730bb4caaf49419 Method

      To compare the structure and findings of the Rush Lung Cancer Screening Program (RLCSP) to two well-known published initiatives: the National Lung Screening Trial (NLST) and Implementation of Lung Cancer Screening in the Veterans Health Administration (LCSDP).

      4c3880bb027f159e801041b1021e88e8 Result

      1 in 29 people screened with the RLCSP has lung cancer, compared with 1 in 68 people screened with the LCSDP, and 1 in 320 screened with the NLST. The RLCSP has a more diverse demographic base, and fewer false positive scans than the NLST or LCSDP.

      8eea62084ca7e541d918e823422bd82e Conclusion

      The NLST is a research study that was conducted for the purpose of testing the efficacy of using a LDCT scan versus chest x-ray to screen for lung cancer.

      The purpose of the LCSDP is to address feasibility of implementing a lung cancer screening program within the VA system; The LCSDP is an implementation project and not a clinical research study.

      RLCSP is a screening program that was implemented in a university hospital setting, which closely adheres to best practices with strong results. Data from the RLCSP supports findings from the NLST that LDCT is an effective scan to screen for lung cancer.

      6f8b794f3246b0c1e1780bb4d4d5dc53

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.